1 Poynard T,Mathurin P,Lai CL,et al.Acomparison of fibrosis progression in chronic liver diseases. JHepatol,2003,38:257-265.
2 Lee KG,Seo YS,An H,et al.Usefulness of non-invasive markers for predicting liver cirrhosis in patients with chronic hepatitis B.JGastroenterol Hepatol,2010,25:94-100.
3 Rockey DC,Bissell DM.Noninvasive measures of liver fibrosis. Hepatology,2006,43(2 Suppl 1):S113-120.
4 Fontana RJ,Litman HJ,Dienstag JL,et al.YKL-40 genetic poly Morphisms and the risk of liver disease progression in patients with advanced fibrosis due to chronic hepatitis C. Liver Int,2012,32:665-674.
5 刘勇鹏,张琳.Fibroscan对HBV感染者肝纤维化诊断的临床研究.中国医药导报,2011,8:42-43.
6 中华医学会肝病学分会,中华医学会感染病学分会.慢性乙型肝炎防治指南(2010年版).中华肝脏病杂志,2011,19:13-24.
7 刘平,慕永平,刘成海.加强肝纤维化的诊断与治疗研究.中华肝脏病杂志,2012,20:561-562.
8 Bataller R,Brenner D.Liver fibrosis.JClin Invest,2005,115:209-218.
9 Scott DR,Levy MT.Liver transient elastography(FibroScan):a place in the management algorith ms of chronic viral hepatitis. Antivir Ther,2010,15:1-11.
10 Tsochatzis EA,Gurusa My KS,Ntaoula S,et al.Elastography for the diagnosis of severity of fibrosis in chronic liver disease:a metaanalysis of diagnosis accuracy.JHepatol,2011,54:650-659.
11 Rathcke CN,Holm kvist J,Husm oen LL,et al. Association of poly Morphisms of the CHI3 L1 gene with asth ma and atopy:a populations-based study of 6514 Danish adults. PLoSOne,2009,4:e6106.
12 Dolganiuc A,Chang S,Kodys K,et al.Hepatitis Cvirus(HCV)core protein-induced,Monocyte-mediated mechanisms of reduced IFN-alpha and plasmacytoid dendritic cell loss in chronic HCVinfection.JIm Munol,2006,177:6758-6768.
13 Zhang YX,Wu WJ,Zhang YZ,et al.Noninvasive assessment of liver fibrosis with combined seru Ma minotransferase/platelet ratio index and hyaluronic acid in patients with chronic hepatitis B. World JGastroenterol,2008,14:7117-7121.
14 Eurich D,Neu Mann UP,Boas-Knoop S,et al.YKL-40-gene poly Morphism affects acute cellular rejection and fibrosis progression after transplantation for hepatitis Cvirus-induced liver disease.JGastroenterol Hepatol,2013,28:153-160.
15 Fontana RJ,Dienstag JL,Bonkovsky HL,et al.Seru Mfibrosis markers are associated with liver disease progression in nonresponder patients with chronic hepatitis C. Gut,2010,59:1401-1409.
16 Schiavon LL,Carvalho-Filho RJ,Narciso-Schiavon JL,et al.YKL-40 and hyaluronic acid(HA)as noninvasive markers of liver fibrosis in kidney transplant patients with HCVchronic infection. Scand JGastroenterol,2010,45:615-622. |
